TransDigm’s Q1 Sales Jump 14% to $2.29 B, Guides $9.85–10.04 B in 2026
TransDigm’s Q1 fiscal 2026 adjusted EPS rose 5% to $8.23, topping estimates by 2.6%, while sales jumped 14% to $2.29 billion, beating consensus by 1.4% on 7.4% organic growth. The company repurchased $100 million of stock, lifted full-year sales guidance to $9.845–10.035 billion and raised adjusted EPS forecast to $37.42–39.34 per share.
1. Q1 Performance
TransDigm’s Q1 fiscal 2026 adjusted EPS rose to $8.23, up 5% year-over-year and surpassing estimate by 2.6%. Sales jumped 14% to $2.29 billion, with organic growth of 7.4%, and gross profit increased 9.3% to $1.35 billion.
2. Capital Allocation and Financial Position
The company repurchased nearly 85,000 shares for $100 million at an average $1,250 per share. Cash on hand fell to $2.53 billion while long-term debt edged up to $29.2 billion and operating cash flow rose to $832 million.
3. 2026 Guidance and Analyst Estimates
TransDigm raised full-year net sales guidance to $9.845–10.035 billion and adjusted EPS outlook to $37.42–39.34 per share. Despite the upward revision, earnings estimates have trended lower post-release, hinting at cautious analyst sentiment.